| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |